HIGHLIGHTS OF THE CANADIAN HEALTHCARE SYSTEM Access to healthcare is based on the need rather than the affordability is the …
Humira patent litigation was resolved between AbbVie and Boehringer Ingelheim
Humira has announced that the patent litigation was resolved between AbbVie and Boehringer Ingelheim. Based on the resolution, AbbVie will …
EMA’s CHMP given a positive opinion on Lorviqua for the treatment of previously treated ALK-positive
European Commission has granted conditional approval for Loqviqua for the treatment of anaplastic lymphoma kinase (ALK)-positive advanced non-small cell lung …
SOBI acquired by Dova Pharmaceuticals
Swedish Orphan Biovitrum AB (SOBI) has announced that it made an agreement to acquire Dova Pharmaceuticals. As per the agreement, …
Cosentyx trial data indicate that the drug is ready to get approval for the fourth indication
Novartis announced the trial data of Cosentyx indicated for axial spondyloarthritis. The results of a 16-week PREVENT study were announced; …
CHMP Positive Opinions: September
CHMP positive opinion of September New approvals · Qtrilmet of AstraZeneca · Rhokiinsa of Aerie Pharmaceuticals · Xospata of Astellas …
Safinamide was approved in Japan
Eisai and Meiji Seika Pharma announced that Equfina tablets were approved in Japan for the treatment of Parkinson’s disease. Meiji …
Novartis capmatinib (INC280) received breakthrough designation by FDA
Novartis announced that capmatinib (INC280) received the breakthrough designation. The product is the first drug indicated for the first line …
Lundbeck acquired Alder BioPharmaceuticals – a company specialized in migraine treatment
Lundbeck announced that it acquired Alder BioPharmaceuticals, a company specialized in the development of therapies indicated for the treatment of …
AstraZeneca’s Farxiga received fast track designation from US FDA
AstraZeneca announced that Farxiga (dapagliflozin) received fast track designation from the US Food and Drug Administration (FDA). The indication for …